Gaithersburg-based Emergent BioSolutions that Richard S. Lindahl, executive vice president and chief financial officer, will retire effective December 31, 2026. Frank Vargo, vice president and treasurer, will step in as interim CFO on January 1, 2027. Lindahl will stay on as a senior executive advisor through March 31, 2027 to support the transition.
The company said the change reflects its ongoing multi-year transformation plan, which aims to strengthen the business, improve operating performance and position Emergent for long-term, sustainable growth.
“During my nearly nine years at Emergent, I am proud of the contributions our team made to the Company’s growth, the resilience we demonstrated through some extraordinarily challenging periods, and the progress we made in strengthening the business for the future”
What’s Next for Lindahl
Lindahl said his immediate focus is supporting a smooth handoff at Emergent. After that, he plans to concentrate on board service and advisory work while making more room for family, friends and travel. He also invited fellow executives and board colleagues interested in governance, business leadership and helping companies through their next stage of growth to connect with him on LinkedIn.
About Richard S. Lindahl
Lindahl joined Emergent in 2018. Earlier, he was CFO of CEB, SVP and treasurer of Sprint Nextel Corporation, and VP of finance at Pocket Communications. He also held roles at MCI Communications and Deloitte. He currently serves on the board of directors of Compass Therapeutics.
About Emergent BioSolutions
Emergent’s mission is to protect and save lives. For more than 25 years, the company has worked to prepare those entrusted with protecting public health. It delivers protective and life-saving solutions for threats including smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies.
